Financings Roundup
Senesco Technologies Inc., of Bridgewater, N.J., entered into a securities purchase agreement to raise $2 million through the sale of 7.69 million shares of common stock. Outside investors also will receive 50 percent warrant coverage at an exercise price of $0.286 per share. Each unit was priced at 26 cents each. Net proceeds are expected to cover working capital and research and development as well as general corporate purposes. The company is developing SNS01-T in multiple myeloma and other B-cell cancers.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.